MDNA - Medicenna Therapeutics GAAP EPS of -$0.02 beats by $0.05 February, 07 2023 07:33 AM Medicenna Therapeutics Corp. Medicenna Therapeutics press release ( NASDAQ: MDNA ): FQ3 GAAP EPS of -$0.02 beats by $0.05 . $36.2 million in cash and cash equivalents at December 31, 2022 For further details see: Medicenna Therapeutics GAAP EPS of -$0.02 beats by $0.05